封面
市場調查報告書
商品編碼
1378570

米諾地爾市場:依類型、給藥途徑、性別、配銷通路、地區

Minoxidil Market, By Type, By Route of Administration, By Gender, By Distribution Channel, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2023年全球米諾地爾市場規模為10.955億美元,預測期內(2023-2030年)年複合成長率為4.8%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 10.955 億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 4.80% 2030年市場規模預測 15.211 億美元
圖 1. 米諾地爾全球市場佔有率(%)(依類型),2023年
米諾地爾市場-IMG1

米諾地爾是一種用於治療高血壓和脫髮的藥物。它是一種抗高血壓血管擴張劑。它可以作為非專利藥物、透過處方箋作為口服錠劑、以及在非處方商店中作為局部溶液或泡沫。米諾地爾是一種外用抗高血壓藥,可促進頭髮生長。米諾地爾主要用於治療雄性脫髮症,也用作其他脫髮症仿單標示外的標籤外治療。米諾地爾是美國食品藥物管理局(FDA)核准的2%米諾地爾溶液,於1986年首次推向市場,1993年推出5%溶液。

市場動態

主要市場參與者擴大採用內部成長策略,例如推出產品以擴大產品系列,預計將在預測期內推動市場成長。例如,2020年11月,美國最大的毛髮再生公司Bosley推出了BosleyRx,這是一種針對男性的處方脫髮藥物的現代方法。透過簡單的線上流程,經驗豐富的醫療專業人員可以診斷並開立預防脫髮和頭髮生長治療的處方。

本研究的主要特點

  • 本報告對全球米諾地爾市場進行了詳細分析,並提出了以2022年為基準年的預測期(2023-2030)的市場規模和年複合成長率。
  • 它還強調了各個細分市場的潛在收益成長機會,並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數,介紹了全球米諾地爾市場的主要企業。
  • 本研究涵蓋的主要企業包括Pfizer Inc.、Atom pharma、Perrigo Company plc、Johnson and Johnson Services, Inc.、Merck KGaA、Actavis Pharma, Inc.、Apotex Inc.、UltiMed Inc.、DS LABORATORIES, INC.、Taisho Pharmaceutical Co., Ltd.、NIKSAN PHARMACEUTICAL、SALVAVIDAS PHARMACEUTICAL PVT.Ltd.、Maruti Futuristic Pharma Pvt.Ltd.、Sun Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories Ltd.、Lupin、Steris Healthcare PVT Ltd.、Salvus Pvt Ltd.、Par Pharmaceutical、QndQ Derma。
  • 本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
  • 米諾地爾全球市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過分析全球米諾地爾市場時所使用的各種策略矩陣來促進決策。

目錄

第1章 調查目的和假設

  • 這項研究的目的
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
  • 影響分析
  • 最近測試啟動
  • 流行病學
  • 合併、收購和合作
  • 監管場景
  • 主要進展
  • PEST分析

第4章 全球米諾地爾市場 - COVID-19感染疾病的影響分析

  • 經濟影響
  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 對需求和供給的影響

第5章 全球米諾地爾市場,依類型,2018-2030

  • 5%米諾地爾
  • 2%米諾地爾

第6章 全球米諾地爾市場,依給藥途徑,2018-2030

  • 口服
  • 外用

第7章 全球米諾地爾市場,依性別,2018-2030

  • 男性
  • 女性

第8章 全球米諾地爾市場,依配銷通路分類,2018-2030

  • 醫院藥房
  • 零售藥房
  • 線上藥房

第9章 全球米諾地爾市場,依地區,2018-2030

  • 北美洲
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章 競爭形勢

  • 公司簡介
    • Pfizer Inc.
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

第11章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4375

The global minoxidil market is estimated to be valued at US$ 1,095.5 million in 2023 and is expected to exhibit a CAGR of 4.8% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1,095.5 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 4.80% 2030 Value Projection: US$ 1,521.1 Mn
Figure 1. Global Minoxidil Market Share (%), By Type, 2023
Minoxidil Market - IMG1

Minoxidil is a medication used for the treatment of high blood pressure and pattern hair loss. It is an antihypertensive vasodilator. It is available as a generic medication by prescription in the oral tablet form and over-the-counter as a topical liquid or foam. Minoxidil, an antihypertensive topical formulation, promotes hair growth. Minoxidil is majorly prescribed for the treatment of androgenetic alopecia, and it is also used as an off-label treatment for other hair loss conditions. Minoxidil is a U.S. Food and Drug Administration (FDA) approved, 2% minoxidil solution and was first launched in the market in 1986, followed by the 5% solution in 1993, and it is majorly applicable in hair growth promotion.

Market Dynamics

The increasing adoption of organic growth strategies, such as product launches, by key market players to expand their product portfolios is expected to drive the market growth over the forecast period. For instance, in November 2020, Bosley, the largest hair restoration company in the U.S., launched BosleyRx, the modern-day approach to prescription hair loss medications for men. Through a simple online process, an experienced medical professional can diagnose and prescribe hair loss prevention and growth treatments.

Key features of the study:

  • This report provides an in-depth analysis of the global minoxidil market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global minoxidil market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • The key companies covered as a part of this study include Pfizer Inc., Atom pharma, Perrigo Company plc, Johnson and Johnson Services, Inc., Merck KGaA, Actavis Pharma, Inc., Apotex Inc., UltiMed Inc., DS LABORATORIES, INC., Taisho Pharmaceutical Co., Ltd., NIKSAN PHARMACEUTICAL, SALVAVIDAS PHARMACEUTICAL PVT. LTD., Maruti Futuristic Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin, Steris Healthcare PVT Ltd, Salvus Pharma, Unison Pharmaceuticals Pvt Ltd, Par Pharmaceutical, and QndQ Derma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global minoxidil market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global minoxidil market

Global Minoxidil Market Detailed Segmentation:

  • By Type:
    • 5% Minoxidil
    • 2% Minoxidil
  • By Route of Administration:
    • Oral
    • Topical
  • By Gender:
    • Male
    • Female
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Pfizer Inc.
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Gender
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Minoxidil Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Minoxidil Market, By Type, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • 5% Minoxidil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • 2% Minoxidil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Minoxidil Market, By Route of Administration, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Minoxidil Market, By Gender, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Male
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Female
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Minoxidil Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

9. Global Minoxidil Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact